A new study points to a possible anti-aging effect from GLP-1 drugs. WFTV has the report on what researchers found.
Recap by typeshit. Full story at WFTV.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
An emergency physician shares a short, pointed reaction to claims that RUO products are a safe route, with a link to more.
The Ministry of Health is asking the healthcare sector to promote careful use of weight and metabolic drugs, warning that misuse could carry risks.
Loading…